Sigba, Cjay .

HRN: 22-77-52  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
CEFUROXIME 1.5GM (VIAL)
03/24/2023
03/29/2023
IV
200mg
Q8H
Pcap C
Waiting Final Action 
03/28/2023
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
03/28/2023
04/03/2023
ORAL
1.5mg
Q12
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: